- Home
- CVAC vs NIE Comparison
CVAC vs NIE Comparison
Compare CVAC & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- NIE
- Stock Information
- Founded
- CVAC 2000
- NIE 2007
- Country
- CVAC Germany
- NIE United States
- Employees
- CVAC N/A
- NIE N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- NIE Investment Managers
- Sector
- CVAC Health Care
- NIE Finance
- Exchange
- CVAC Nasdaq
- NIE Nasdaq
- Market Cap
- CVAC 818.8M
- NIE 697.4M
- IPO Year
- CVAC 2020
- NIE N/A
- Fundamental
- Price
- CVAC $2.77
- NIE $22.11
- Analyst Decision
- CVAC Hold
- NIE
- Analyst Count
- CVAC 3
- NIE 0
- Target Price
- CVAC $10.00
- NIE N/A
- AVG Volume (30 Days)
- CVAC 620.8K
- NIE 70.5K
- Earning Date
- CVAC 05-22-2025
- NIE 01-01-0001
- Dividend Yield
- CVAC N/A
- NIE 9.04%
- EPS Growth
- CVAC N/A
- NIE N/A
- EPS
- CVAC N/A
- NIE N/A
- Revenue
- CVAC $70,565,734.00
- NIE N/A
- Revenue This Year
- CVAC $742.57
- NIE N/A
- Revenue Next Year
- CVAC N/A
- NIE N/A
- P/E Ratio
- CVAC N/A
- NIE N/A
- Revenue Growth
- CVAC 75.11
- NIE N/A
- 52 Week Low
- CVAC $2.22
- NIE $18.61
- 52 Week High
- CVAC $5.28
- NIE $22.47
- Technical
- Relative Strength Index (RSI)
- CVAC 38.24
- NIE 35.69
- Support Level
- CVAC $2.78
- NIE $22.22
- Resistance Level
- CVAC $3.33
- NIE $22.86
- Average True Range (ATR)
- CVAC 0.15
- NIE 0.40
- MACD
- CVAC -0.00
- NIE 0.05
- Stochastic Oscillator
- CVAC 8.20
- NIE 34.58
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments such as aerospace and defense, banks, IT services, software, and others.